Apr 21, 2025, 18:50

NCI: Paul Calabresi Career Development Award for Clinical Oncology

The NCI Paul Calabresi Career Development Award (K12) supports the training of clinician-scientists (M.D., D.O., Pharm.D., or Ph.D.-level nurses) in clinical and translational cancer research. The program aims to increase the number of well-trained, independent investigators in clinical oncology and allows for participation in or leadership of clinical trials. This award is not intended for laboratory-based research and provides institutional support for up to 5 years. The award is renewable.

Eligibility Criteria

Principal Investigator (PI):

Must be a U.S. citizen, non-citizen national, or permanent resident
Must be an established investigator (Associate or Full Professor)
Must have active R01 or R01-equivalent cancer-related funding (≥3 years and ≥$150,000/year in direct costs)

Mentors:

Must represent a diversity of research disciplines
Must have independent R01 or R01-like cancer-focused research support

Scholars:

Must be a U.S. citizen, non-citizen national, or permanent resident
Must hold a clinical degree (M.D., D.O., Pharm.D., or Ph.D. in nursing or equivalent)
Cannot be in residency at the time of award
Must commit a minimum of 9 person-months (75%) full-time effort (surgeon-scientists may request 6–9 months with strong justification)

Funding Details

K12 Program Budget:

Up to $750,000/year in direct costs
Year 1 capped at $50,000 (for recruitment, advisory board, curriculum planning, etc.)

PI Support:

Up to 1.2 person months total for program directors/principal investigators

Scholar Support:

Salary: Up to $100,000/year + fringe benefits
Research development: Up to $30,000/year

Other Costs:

Travel to K12 community conference: $1,500 per person (NOT-CA-20-088)
8% F&A (indirect costs)

Deadline

Refer to PAR-22-136 for application deadlines
Applications due by 5:00 PM local time
If deadline falls on a weekend/holiday, it is extended to the next business day

Where to Go for Further Information

cancer Cancer research career development clinical oncology clinician scientist K12 award medical research grants National Cancer Institute NCI OncoDaily Oncology oncology grants Oncology Training Paul Calabresi physician-scientist translational research

Where to Study to Become ASCO President: 2025 Institutional Rankings

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book

April is Head and Neck Cancer Awareness Month